ROYAL GOLD INC (RGLD)       127.82  +1 (+0.79%)

127.82  +1 (+0.79%)

US7802871084 - Common Stock - After market: 127.82 0 (0%)


Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to RGLD. RGLD was compared to 969 industry peers in the Metals & Mining industry. Both the profitability and the financial health of RGLD get a neutral evaluation. Nothing too spectacular is happening here. RGLD is valued expensive and it does not seem to be growing.




Profitability

Profitability Rating

4

RGLD's Profit Margin of 39.62% is amongst the best returns of the industry. RGLD outperforms 83% of its industry peers. The industry average Profit Margin is 14.60%.
RGLD's Return On Assets of 6.76% is in line with the rest of the industry. The industry average Return On Assets is 7.48%.

RGLD has a Piotroski-F score of 4.00. This indicates an average health and profitability for RGLD.
RGLD has a Return On Equity of 8.72%. This is below the industry average of 12.52%.
VS Industry

ROA (6.76%) VS Industry: 45% outperformed.

0.09
231.29

ROE (8.72%) VS Industry: 36% outperformed.

0.10
178.28

Profit Margin (39.62%) VS Industry: 83% outperformed.

0.68
1,966.43

Valuation

Valuation Rating

0

When comparing the current price to the book value of RGLD, we can conclude it is valued correctly. It is trading at 3.06 times its book value.
The Price/Earnings Ratio is 37.37, which means the current valuation is very expensive for RGLD.
With a Price/Earning Ratio of 37.37, RGLD is valued a higher than the industry average, which is at 13.00. 81% of the companies listed in the same industry are cheaper than RGLD!
The Forward Price/Earnings Ratio of 32.84 indicates a quite expensive current valuation of RGLD.

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
Compared to an average industry price book ratio of 1.68, RGLD is valued more expensive than its industry peers.
Compared to an average industry Enterprise Value to EBITDA ratio of 6.23, RGLD is valued more expensive than its industry peers. 80% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (37.37) VS Industry: 19% outperformed.

1,023.00
0.15

Price/Book (3.06) VS Industry: 28% outperformed.

6,836.00
0.03

Enterprise Value/ EBITDA (18.8) VS Industry: 20% outperformed.

374.61
0.07

Growth

Growth Rating

3

The Earnings Per Share has been growing by 18.08% on average over the past 5 years. This is quite good.
RGLD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.79%.
The Earnings Per Share is expected to grow by 1.51% on average over the next 5 years.
The Revenue has decreased by -7.71% in the past year.

RGLD shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 6.47% yearly.
RGLD is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 5.58% yearly.
The Revenue growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS18.08% 33.73% -5.79% 13.79% 10.56% 8% 1.51%
Revenue6.47% 12.55% -7.71% 14.08% 8.17% 5.58% N/A

Health

Health Rating

6

A Current Ratio of 2.92 indicates that RGLD has no problem at all paying its short term obligations.
RGLD has a Quick Ratio of 2.72. This indicates that RGLD is financially healthy and has no problem in meeting its short term obligations.
An Altman-Z score of 6.99 indicates that RGLD is not in any danger for bankruptcy at the moment.
When comparing the Altman-Z score to an average industry score of 2.51, RGLD is in better financial health than the average industry peer.

The Current Ratio is in line with the industry averages, which is at 2.56.
RGLD has a Quick Ratio comparable to the industry average, which is at 2.16.
The Piotroski-F score of RGLD is 4.00. This is a neutral score and indicates average health and profitability for RGLD.
RGLD has one of the worst Debt to Equity ratios in its industry. 86% of its industry peers require less debt for financing their operations.
VS Industry

Debt/Equity (0.21) VS Industry: 14% outperformed.

4.14
0.00

Quick Ratio (2.72) VS Industry: 55% outperformed.

0.00
178.59

Current Ratio (2.92) VS Industry: 53% outperformed.

0.00
178.59

Altman-Z (6.99) VS Industry: 67% outperformed.

-22,403.48
2,514.55

Dividend

Dividend Rating

4

38.47% of the earnings are spent on dividend by RGLD. This is a low number and sustainable payout ratio.
RGLD has been paying a dividend for at least 10 years, so it has a reliable track record.
RGLD has a Yearly Dividend Yield of 1.19%.

Compared to an average industry Dividend Yield of 2.10, RGLD is paying slightly less dividend.
With a Dividend Yield of 1.19, RGLD pays less dividend than the S&P500 average, which is at 2.60.
VS Industry

Dividend Yield (1.19%) VS Industry: 24% outperformed.

0.27
24.74

ROYAL GOLD INC127.82

NASDAQ:RGLD (3/29/2023, 7:00:02 PM)+1 (+0.79%)

After market: 127.82 0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-15 2023-02-15/amc
Earnings (Next)N/A N/A
Inst Owners85.97%
Inst Owner Change8.68%
Ins Owners0.28%
Ins Owner Change12.38%
Market Cap8.39B
Analysts73
Price Target144.45 (13.01%)
Dividend
Industry RankSector Rank
Dividend Yield 1.19%
Dividend Growth(5Y)N/A
DP38.47%
Div Incr Years7
Div Non Decr Years7
Ex-Date04-05 2023-04-05 (0.375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.4%
Min EPS beat(2)-5.05%
Max EPS beat(2)9.86%
EPS beat(4)2
Avg EPS beat(4)0.99%
Min EPS beat(4)-12.15%
Max EPS beat(4)11.29%
Revenue beat(2)1
Avg Revenue beat(2)-1.86%
Min Revenue beat(2)-7.97%
Max Revenue beat(2)4.24%
Revenue beat(4)2
Avg Revenue beat(4)0.54%
Min Revenue beat(4)-7.97%
Max Revenue beat(4)12.43%
PT rev (1m)-0.49%
PT rev (3m)9.11%
EPS NQ rev (1m)0.95%
EPS NQ rev (3m)-20.08%
EPS NY rev (1m)0.55%
EPS NY rev (3m)0.55%
Revenue NQ rev (1m)7.19%
Revenue NQ rev (3m)-2.99%
Revenue NY rev (1m)5.03%
Revenue NY rev (3m)5.03%
Valuation
Industry RankSector Rank
PE 37.37
Fwd PE 32.84
P/S 13.91
P/FCF N/A
P/OCF 20.1
P/B 3.06
P/tB 3.06
EV/EBITDA 18.8
EPS(TTM)3.42
EY2.68%
EPS(NY)3.89
Fwd EY3.04%
FCF(TTM)-7.69
FCFYN/A
OCF(TTM)6.36
OCFY4.97%
SpS9.19
BVpS41.76
TBVpS41.76
PEG (NY)2.71
PEG (5Y)2.07
Profitability
Industry RankSector Rank
ROA 6.76%
ROE 8.72%
ROIC 7.35%
ROICexc 7.61%
ROICexgc 7.61%
OM 47.74%
PM 39.62%
GM 83.15%
ROICexgc(3y)8.77%
ROICexcg growth 3Y13.44%
ROICexcg growth 5Y11.86%
ROICexc(3y)8.77%
ROICexc growth 3Y13.44%
ROICexc growth 5Y11.86%
OM growth 3Y12.81%
OM growth 5Y7.6%
PM growth 3Y21.35%
PM growth 5Y11.46%
GM growth 3Y1%
GM growth 5Y0.82%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 1.22
Cap/Depr 515.36%
Profit Quality N/A
Current Ratio 2.92
Quick Ratio 2.72
Altman-Z 6.99
F-Score4
WACC10.08%
ROIC/WACC0.75
Cap/Depr(3y)231.97%
Cap/Depr(5y)140.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-5.79%
EPS 3Y33.73%
EPS 5Y18.08%
EPS growth Q2Q-13.33%
EPS Next Y13.79%
EPS Next 2Y10.56%
EPS Next 3Y8%
EPS Next 5Y1.51%
Revenue growth 1Y-7.71%
Revenue growth 3Y12.55%
Revenue growth 5Y6.47%
Revenue growth Q2Q-3.29%
Revenue Next Year14.08%
Revenue Next 2Y8.17%
Revenue Next 3Y5.58%
Revenue Next 5YN/A
EBIT growth 1Y-12.31%
EBIT growth 3Y26.97%
EBIT growth 5Y14.57%
EBIT Next Year71.09%
EBIT Next 3Y20.95%
EBIT Next 5Y11.09%
FCF growth 1Y-311.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.5%
OCF growth 3Y18.13%
OCF growth 5Y9.35%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA